Report cover image

Cancer Diagnostics Market, By Test Type (Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, CA-19 Tests, HER2 Tests, BRCA Tests, ALK Tests, CEA Tests, EGFR Mutation Tests, KRAS Mutation Tests, Others)), Imaging (Ultrasound, Mammography, MRI Scan, PE

Publisher Coherent Market Insights
Published May 02, 2022
Length 188 Pages
SKU # CMI17212443

Description

Cancer Diagnostics Market, By Test Type (Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, CA-19 Tests, HER2 Tests, BRCA Tests, ALK Tests, CEA Tests, EGFR Mutation Tests, KRAS Mutation Tests, Others)), Imaging (Ultrasound, Mammography, MRI Scan, PET Scan, CT Scan, SPECT & Others), Biopsy (Needle Biopsy, Endoscopic Biopsy, Bone Marrow Biopsy, Others), Liquid Biopsy Immunohistochemistry In Situ Hybridization), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancers, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, Others), By End User (Hospital Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Cancer diagnostics are procedures used for the identification of cancer with or without incision in the body. Detection and treatment of cancer at early stages are important for long-term survival. Non-invasive cancer detection method is found to be an increasing choice of interest, owing to its painless or minimal pain method of diagnostic coupled with more accurate results. Molecular based diagnostic methods are expected to increase during the forecast period due to launches of new biomarker based detection methods. Moreover, factors like increasing incidence of cancer, increasing cancer screening rate, government initiatives, and emerging technologies such as next generation sequencing are expected to drive the market during the forecast period.
Restraints of the Global Cancer Diagnostics Market
Major factors hampering the growth of the cancer diagnostics market during the forecast period constitutes of high costs, and inadequate reimbursement.
Key features of the study:
This report provides in-depth analysis of the global cancer diagnostics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global cancer diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Siemens AG, Bio Rad Laboratories Inc., GE Healthcare, Illumina, Inc., Koninklijke Philips N.V., Toshiba Medical Systems Corporation, Agilent Technologies, Inc., Aurora Imaging Technologies, Inc., and Quest Diagnostics
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global cancer diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Cancer Diagnostics Market, By Test Type:
Tumor Biomarkers Tests
PSA Tests
CTC Tests
AFP Tests
CA-19 Tests
HER2 Tests
BRCA Tests
ALK Tests
CEA Tests
EGFR Mutation Tests
KRAS Mutation Tests
Others
Imaging
Ultrasound
Mammography
MRI Scan
PET Scan
CT Scan
SPECT & Others
Biopsy
Needle Biopsy
Endoscopic Biopsy
Bone Marrow Biopsy
Others
Liquid Biopsy
Immunohistochemistry
In Situ Hybridization
Global Cancer Diagnostics Market, By Cancer Type:
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Blood Cancers
Prostate Cancer
Ovarian Cancer
Stomach Cancer
Liver Cancer
Others
Global Cancer Diagnostics Market, By End User:
Hospital Associated Labs
Independent Diagnostic Laboratories
Diagnostic Imaging Centers
Cancer Research Institutes
Others
Global Cancer Diagnostics Market, By Geography:
North America
By Test Type
Tumor Biomarkers Tests
PSA Tests
CTC Tests
AFP Tests
CA-19 Tests
HER2 Tests
BRCA Tests
ALK Tests
CEA Tests
EGFR Mutation Tests
KRAS Mutation Tests
Others
Imaging
Ultrasound
Mammography
MRI Scan
PET Scan
CT Scan
SPECT & Others
Biopsy
Needle Biopsy
Endoscopic Biopsy
Bone Marrow Biopsy
Others
Liquid Biopsy
Immunohistochemistry
In Situ Hybridization
By Cancer Type
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Blood Cancers
Prostate Cancer
Ovarian Cancer
Stomach Cancer
Liver Cancer
Others
By End User
Hospital Associated Labs
Independent Diagnostic Laboratories
Diagnostic Imaging Centers
Cancer Research Institutes
Others
By Country:
U.S.
Canada
Europe
By Test Type
Tumor Biomarkers Tests
PSA Tests
CTC Tests
AFP Tests
CA-19 Tests
HER2 Tests
BRCA Tests
ALK Tests
CEA Tests
EGFR Mutation Tests
KRAS Mutation Tests
Others
Imaging
Ultrasound
Mammography
MRI Scan
PET Scan
CT Scan
SPECT & Others
Biopsy
Needle Biopsy
Endoscopic Biopsy
Bone Marrow Biopsy
Others
Liquid Biopsy
Immunohistochemistry
In Situ Hybridization
By Cancer Type
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Blood Cancers
Prostate Cancer
Ovarian Cancer
Stomach Cancer
Liver Cancer
Others
By End User
Hospital Associated Labs
Independent Diagnostic Laboratories
Diagnostic Imaging Centers
Cancer Research Institutes
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Test Type
Tumor Biomarkers Tests
PSA Tests
CTC Tests
AFP Tests
CA-19 Tests
HER2 Tests
BRCA Tests
ALK Tests
CEA Tests
EGFR Mutation Tests
KRAS Mutation Tests
Others
Imaging
Ultrasound
Mammography
MRI Scan
PET Scan
CT Scan
SPECT & Others
Biopsy
Needle Biopsy
Endoscopic Biopsy
Bone Marrow Biopsy
Others
Liquid Biopsy
Immunohistochemistry
In Situ Hybridization
By Cancer Type
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Blood Cancers
Prostate Cancer
Ovarian Cancer
Stomach Cancer
Liver Cancer
Others
By End User
Hospital Associated Labs
Independent Diagnostic Laboratories
Diagnostic Imaging Centers
Cancer Research Institutes
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Test Type
Tumor Biomarkers Tests
PSA Tests
CTC Tests
AFP Tests
CA-19 Tests
HER2 Tests
BRCA Tests
ALK Tests
CEA Tests
EGFR Mutation Tests
KRAS Mutation Tests
Others
Imaging
Ultrasound
Mammography
MRI Scan
PET Scan
CT Scan
SPECT & Others
Biopsy
Needle Biopsy
Endoscopic Biopsy
Bone Marrow Biopsy
Others
Liquid Biopsy
Immunohistochemistry
In Situ Hybridization
By Cancer Type
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Blood Cancers
Prostate Cancer
Ovarian Cancer
Stomach Cancer
Liver Cancer
Others
By End User
Hospital Associated Labs
Independent Diagnostic Laboratories
Diagnostic Imaging Centers
Cancer Research Institutes
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Test Type
Tumor Biomarkers Tests
PSA Tests
CTC Tests
AFP Tests
CA-19 Tests
HER2 Tests
BRCA Tests
ALK Tests
CEA Tests
EGFR Mutation Tests
KRAS Mutation Tests
Others
Imaging
Ultrasound
Mammography
MRI Scan
PET Scan
CT Scan
SPECT & Others
Biopsy
Needle Biopsy
Endoscopic Biopsy
Bone Marrow Biopsy
Others
Liquid Biopsy
Immunohistochemistry
In Situ Hybridization
By Cancer Type
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Blood Cancers
Prostate Cancer
Ovarian Cancer
Stomach Cancer
Liver Cancer
Others
By End User
Hospital Associated Labs
Independent Diagnostic Laboratories
Diagnostic Imaging Centers
Cancer Research Institutes
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Test Type
Tumor Biomarkers Tests
PSA Tests
CTC Tests
AFP Tests
CA-19 Tests
HER2 Tests
BRCA Tests
ALK Tests
CEA Tests
EGFR Mutation Tests
KRAS Mutation Tests
Others
Imaging
Ultrasound
Mammography
MRI Scan
PET Scan
CT Scan
SPECT & Others
Biopsy
Needle Biopsy
Endoscopic Biopsy
Bone Marrow Biopsy
Others
Liquid Biopsy
Immunohistochemistry
In Situ Hybridization
By Cancer Type
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Blood Cancers
Prostate Cancer
Ovarian Cancer
Stomach Cancer
Liver Cancer
Others
By End User
Hospital Associated Labs
Independent Diagnostic Laboratories
Diagnostic Imaging Centers
Cancer Research Institutes
Others
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Abbott Laboratories *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Inc.
Siemens AG
Bio Rad Laboratories Inc.
GE Healthcare
Illumina, Inc.
Koninklijke Philips N.V.
Toshiba Medical Systems Corporation
Agilent Technologies, Inc.
Aurora Imaging Technologies, Inc.
Quest Diagnostics
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

188 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Test Type
Market Snippet, By Cancer Type
Market Snippet, By End User
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Regulatory Scenario
PEST Analysis
COVID-19 Impact Analysis
4. Global Cancer Diagnostics Market, By Test Type, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Tumor Biomarkers Tests
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
PSA Tests
CTC Tests
AFP Tests
CA-19 Tests
HER2 Tests
BRCA Tests
ALK Tests
CEA Tests
EGFR Mutation Tests
KRAS Mutation Tests
Others
Imaging
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Ultrasound
Mammography
MRI Scan
PET Scan
CT Scan
SPECT & Others
Biopsy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Needle Biopsy
Endoscopic Biopsy
Bone Marrow Biopsy
Others
Liquid Biopsy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Immunohistochemistry
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
In Situ Hybridization
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
5. Global Cancer Diagnostics Market, By Cancer Type, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Breast Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Lung Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Colorectal Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Melanoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Blood Cancers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Prostate Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Ovarian Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Stomach Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Liver Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Global Cancer Diagnostics Market, By End User, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Hospital Associated Labs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Independent Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Diagnostic Imaging Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Cancer Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Global Cancer Diagnostics Market, By Regions, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Company Profiles
Abbott Laboratories
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
F. Hoffmann-La Roche Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Thermo Fisher Scientific Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Siemens AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Bio Rad Laboratories Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
GE Healthcare
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Illumina, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Koninklijke Philips N.V.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Toshiba Medical Systems Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Agilent Technologies, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Aurora Imaging Technologies, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Quest Diagnostics
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 38 market data tables and 56 figures on “Cancer Diagnostics Market – Global forecast to 2028.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us